{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:07:48Z","timestamp":1791248868780,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":555,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1038\/mt.2015.4","type":"journal-article","created":{"date-parts":[[2015,1,13]],"date-time":"2015-01-13T12:16:06Z","timestamp":1421151366000},"page":"769-778","source":"Crossref","is-referenced-by-count":210,"title":["Enhancing Antitumor Efficacy of Chimeric Antigen Receptor T Cells Through Constitutive CD40L Expression"],"prefix":"10.1016","volume":"23","author":[{"given":"Kevin J","family":"Curran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrijs A","family":"Seinstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Nikhamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yelena","family":"Usachenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayenne G","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence","family":"Purdon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hollie J","family":"Pegram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renier J","family":"Brentjens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2015.4_bib1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/jgm.2604","article-title":"Chimeric antigen receptors for T cell immunotherapy: current understanding and future directions","volume":"14","author":"Curran","year":"2012","journal-title":"J Gene Med"},{"key":"10.1038\/mt.2015.4_bib2","doi-asserted-by":"crossref","first-page":"177ra38","DOI":"10.1126\/scitranslmed.3005930","article-title":"CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia","volume":"5","author":"Brentjens","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1038\/mt.2015.4_bib3","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1182\/blood-2011-04-348540","article-title":"Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias","volume":"118","author":"Brentjens","year":"2011","journal-title":"Blood"},{"key":"10.1038\/mt.2015.4_bib4","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa1103849","article-title":"Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia","volume":"365","author":"Porter","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2015.4_bib5","doi-asserted-by":"crossref","first-page":"224ra25","DOI":"10.1126\/scitranslmed.3008226","article-title":"Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia","volume":"6","author":"Davila","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1038\/mt.2015.4_bib6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev-immunol-031210-101324","article-title":"Natural innate and adaptive immunity to cancer","volume":"29","author":"Vesely","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"10.1038\/mt.2015.4_bib7","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1215134","article-title":"Chimeric antigen receptor-modified T cells for acute lymphoid leukemia","volume":"368","author":"Grupp","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2015.4_bib8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/357080a0","article-title":"Molecular and biological characterization of a murine ligand for CD40","volume":"357","author":"Armitage","year":"1992","journal-title":"Nature"},{"key":"10.1038\/mt.2015.4_bib9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/PL00000776","article-title":"The CD40\/CD154 receptor\/ligand dyad","volume":"58","author":"Sch\u00f6nbeck","year":"2001","journal-title":"Cell Mol Life Sci"},{"key":"10.1038\/mt.2015.4_bib10","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1182\/blood.V76.12.2449.2449","article-title":"Temporal association of CD40 antigen expression with discrete stages of human B-cell ontogeny and the efficacy of anti-CD40 immunotoxins against clonogenic B-lineage acute lymphoblastic leukemia as well as B-lineage non-Hodgkin's lymphoma cells","volume":"76","author":"Uckun","year":"1990","journal-title":"Blood"},{"key":"10.1038\/mt.2015.4_bib11","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1002\/eji.1830250742","article-title":"Recombinant CD30 ligand and CD40 ligand share common biological activities on Hodgkin and Reed-Sternberg cells","volume":"25","author":"Gruss","year":"1995","journal-title":"Eur J Immunol"},{"key":"10.1038\/mt.2015.4_bib12","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000226945","article-title":"Nasopharyngeal carcinoma and lymphoinfiltration","volume":"48","author":"Zong","year":"1991","journal-title":"Oncology"},{"key":"10.1038\/mt.2015.4_bib13","first-page":"1843","article-title":"Expression of functional CD40 on human osteosarcoma and Ewing's sarcoma cells","volume":"4","author":"Lollini","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1038\/mt.2015.4_bib14","first-page":"1953","article-title":"CD40 is a prognostic marker in primary cutaneous malignant melanoma","volume":"149","author":"van den Oord","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1038\/mt.2015.4_bib15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1023\/A:1006012607452","article-title":"CD40 is functionally expressed on human breast carcinomas: variable inducibility by cytokines and enhancement of Fas-mediated apoptosis","volume":"50","author":"Wingett","year":"1998","journal-title":"Breast Cancer Res Treat"},{"key":"10.1038\/mt.2015.4_bib16","first-page":"27","article-title":"Differential expression of CD40 and CD95 in ovarian carcinoma","volume":"25","author":"Ciaravino","year":"2004","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1038\/mt.2015.4_bib17","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.4049\/jimmunol.162.7.4140","article-title":"CD40 ligand-CD40 interaction induces chemokines in cervical carcinoma cells in synergism with IFN-gamma","volume":"162","author":"Altenburg","year":"1999","journal-title":"J Immunol"},{"key":"10.1038\/mt.2015.4_bib18","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1084\/jem.184.2.747","article-title":"Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation","volume":"184","author":"Cella","year":"1996","journal-title":"J Exp Med"},{"key":"10.1038\/mt.2015.4_bib19","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/jlb.67.5.607","article-title":"The critical role of CD40\/CD40L in the CD4-dependent generation of CD8+ T cell immunity","volume":"67","author":"Clarke","year":"2000","journal-title":"J Leukoc Biol"},{"key":"10.1038\/mt.2015.4_bib20","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.4049\/jimmunol.152.4.1523","article-title":"CD40 preferentially costimulates activation of CD4+ T lymphocytes","volume":"152","author":"Cayabyab","year":"1994","journal-title":"J Immunol"},{"key":"10.1038\/mt.2015.4_bib21","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/eji.1830260732","article-title":"Accessory signaling by CD40 for T cell activation: induction of Th1 and Th2 cytokines and synergy with interleukin-12 for interferon-gamma production","volume":"26","author":"Peng","year":"1996","journal-title":"Eur J Immunol"},{"key":"10.1038\/mt.2015.4_bib22","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.4049\/jimmunol.1102319","article-title":"Cutting edge: CD40-CD40 ligand pathway plays a critical CD8-intrinsic and -extrinsic role during rescue of exhausted CD8 T cells","volume":"187","author":"Bhadra","year":"2011","journal-title":"J Immunol"},{"key":"10.1038\/mt.2015.4_bib23","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1126\/science.1072615","article-title":"A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory","volume":"297","author":"Bourgeois","year":"2002","journal-title":"Science"},{"key":"10.1038\/mt.2015.4_bib24","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3109\/08830185.2012.698338","article-title":"The use of agonistic anti-CD40 therapy in treatments for cancer","volume":"31","author":"Khong","year":"2012","journal-title":"Int Rev Immunol"},{"key":"10.1038\/mt.2015.4_bib25","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1158\/1078-0432.CCR-12-2064","article-title":"Agonistic CD40 antibodies and cancer therapy","volume":"19","author":"Vonderheide","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1038\/mt.2015.4_bib26","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1182\/blood.V96.9.2917","article-title":"CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia","volume":"96","author":"Wierda","year":"2000","journal-title":"Blood"},{"key":"10.1038\/mt.2015.4_bib27","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nm827","article-title":"Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15","volume":"9","author":"Brentjens","year":"2003","journal-title":"Nat Med"},{"key":"10.1038\/mt.2015.4_bib28","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1182\/blood-2013-02-483586","article-title":"CD40L expression permits CD8+ T cells to execute immunologic helper functions","volume":"122","author":"Frentsch","year":"2013","journal-title":"Blood"},{"key":"10.1038\/mt.2015.4_bib29","doi-asserted-by":"crossref","first-page":"95ra73","DOI":"10.1126\/scitranslmed.3002842","article-title":"T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia","volume":"3","author":"Kalos","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1038\/mt.2015.4_bib30","article-title":"Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor","author":"Kochenderfer","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1038\/mt.2015.4_bib31","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1038\/nm1676","article-title":"T cell-encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection","volume":"13","author":"Stephan","year":"2007","journal-title":"Nat Med"},{"key":"10.1038\/mt.2015.4_bib32","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1182\/blood-2012-10-385591","article-title":"The role of B7 family molecules in hematologic malignancy","volume":"121","author":"Greaves","year":"2013","journal-title":"Blood"},{"key":"10.1038\/mt.2015.4_bib33","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1182\/blood.V94.2.754","article-title":"High frequency of adhesion defects in B-lineage acute lymphoblastic leukemia","volume":"94","author":"Geijtenbeek","year":"1999","journal-title":"Blood"},{"key":"10.1038\/mt.2015.4_bib34","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1126\/science.7539157","article-title":"Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity","volume":"268","author":"Rieux-Laucat","year":"1995","journal-title":"Science"},{"key":"10.1038\/mt.2015.4_bib35","doi-asserted-by":"crossref","first-page":"8200","DOI":"10.1073\/pnas.92.18.8200","article-title":"Follicular lymphomas can be induced to present alloantigen efficiently: a conceptual model to improve their tumor immunogenicity","volume":"92","author":"Schultze","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2015.4_bib36","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1182\/blood.V88.4.1375.bloodjournal8841375","article-title":"CD4+ T-cell induction of Fas-mediated apoptosis in Burkitt's lymphoma B cells","volume":"88","author":"Schattner","year":"1996","journal-title":"Blood"},{"key":"10.1038\/mt.2015.4_bib37","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1182\/blood-2003-12-4392","article-title":"Manipulating dendritic cell biology for the active immunotherapy of cancer","volume":"104","author":"O\u2019Neill","year":"2004","journal-title":"Blood"},{"key":"10.1038\/mt.2015.4_bib38","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.4049\/jimmunol.0903111","article-title":"Activation of tolerogenic dendritic cells in the tumor draining lymph nodes by CD8+ T cells engineered to express CD40 ligand","volume":"184","author":"Higham","year":"2010","journal-title":"J Immunol"},{"key":"10.1038\/mt.2015.4_bib39","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1182\/blood-2011-12-400044","article-title":"Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning","volume":"119","author":"Pegram","year":"2012","journal-title":"Blood"},{"key":"10.1038\/mt.2015.4_bib40","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nri1001","article-title":"Interleukin-12 and the regulation of innate resistance and adaptive immunity","volume":"3","author":"Trinchieri","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1038\/mt.2015.4_bib41","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/CJI.0b013e318288f8c1","article-title":"Upregulation of adhesion molecules on leukemia targets improves the efficacy of cytotoxic T cells transduced with chimeric anti-CD19 receptor","volume":"36","author":"Laurin","year":"2013","journal-title":"J Immunother"},{"key":"10.1038\/mt.2015.4_bib42","doi-asserted-by":"crossref","first-page":"13964","DOI":"10.1074\/jbc.M601553200","article-title":"Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human","volume":"281","author":"Bossen","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2015.4_bib43","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/3233","article-title":"Thymic lymphoproliferative disease after successful correction of CD40 ligand deficiency by gene transfer in mice","volume":"4","author":"Brown","year":"1998","journal-title":"Nat Med"},{"key":"10.1038\/mt.2015.4_bib44","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJMoa1106152","article-title":"Inducible apoptosis as a safety switch for adoptive cell therapy","volume":"365","author":"Di Stasi","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2015.4_bib45","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1089\/hum.2009.001","article-title":"Efficient human hematopoietic cell transduction using RD114- and GALV-pseudotyped retroviral vectors produced in suspension and serum-free media","volume":"20","author":"Ghani","year":"2009","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2015.4_bib46","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1182\/blood-2002-04-1093","article-title":"Differential CD52 expression by distinct myeloid dendritic cell subsets: implications for alemtuzumab activity at the level of antigen presentation in allogeneic graft-host interactions in transplantation","volume":"101","author":"Ratzinger","year":"2003","journal-title":"Blood"},{"key":"10.1038\/mt.2015.4_bib47","doi-asserted-by":"crossref","first-page":"6733","DOI":"10.1073\/pnas.92.15.6733","article-title":"Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells","volume":"92","author":"Rivi\u00e8re","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"issue":"18 Pt 1","key":"10.1038\/mt.2015.4_bib48","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.1158\/1078-0432.CCR-07-0674","article-title":"Genetically targeted T cells eradicate systemic acute lymphoblastic leukemia xenografts","volume":"13","author":"Brentjens","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1038\/mt.2015.4_bib49","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/sj.neo.7900018","article-title":"Cancer patient T cells genetically targeted to prostate-specific membrane antigen specifically lyse prostate cancer cells and release cytokines in response to prostate-specific membrane antigen","volume":"1","author":"Gong","year":"1999","journal-title":"Neoplasia"},{"key":"10.1038\/mt.2015.4_bib50","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nm.1930","article-title":"Sensitive in vivo imaging of T cells using a membrane-bound Gaussia princeps luciferase","volume":"15","author":"Santos","year":"2009","journal-title":"Nat Med"},{"key":"10.1038\/mt.2015.4_bib51","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1089\/hum.2007.088","article-title":"Multifactorial optimization of gammaretroviral gene transfer into human T lymphocytes for clinical application","volume":"18","author":"Quint\u00e1s-Cardama","year":"2007","journal-title":"Hum Gene Ther"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500161630096X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500161630096X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T21:47:46Z","timestamp":1690840066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152500161630096X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S152500161630096X"],"URL":"https:\/\/doi.org\/10.1038\/mt.2015.4","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}